Two Sigma Investments’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-20,401
| Closed | -$301K | – | 3465 |
|
|
2024
Q1 | $301K | Sell |
20,401
-1,433
| -7% | -$20.1K | ﹤0.01% | 2559 |
|
|
2023
Q4 | $293K | Buy |
+21,834
| New | +$276K | ﹤0.01% | 2706 |
|
|
2023
Q1 | – | Sell |
-42,490
| Closed | -$487K | – | 3366 |
|
|
2022
Q4 | $487K | Buy |
42,490
+20,971
| +97% | +$173K | ﹤0.01% | 2036 |
|
|
2022
Q3 | $81K | Sell |
21,519
-3,400
| -14% | -$15.7K | ﹤0.01% | 2260 |
|
|
2022
Q2 | $148K | Sell |
24,919
-5,820
| -19% | -$32.8K | ﹤0.01% | 2218 |
|
|
2022
Q1 | $194K | Sell |
30,739
-5,227
| -15% | -$29.4K | ﹤0.01% | 2343 |
|
|
2021
Q4 | $141K | Sell |
35,966
-9,949
| -22% | -$43.2K | ﹤0.01% | 3995 |
|
|
2021
Q3 | $222K | Sell |
45,915
-16,204
| -26% | -$84.5K | ﹤0.01% | 3893 |
|
|
2021
Q2 | $397K | Sell |
62,119
-154,722
| -71% | -$1.02M | ﹤0.01% | 3291 |
|
|
2021
Q1 | $1.36M | Sell |
216,841
-50,714
| -19% | -$362K | ﹤0.01% | 2036 |
|
|
2020
Q4 | $1.84M | Buy |
+267,555
| New | +$1.32M | 0.01% | 1547 |
|
|
2020
Q1 | – | Sell |
-18,714
| Closed | -$59K | – | 4148 |
|
|
2019
Q4 | $59K | Sell |
18,714
-3,600
| -16% | -$14.4K | ﹤0.01% | 3561 |
|
|
2019
Q3 | $100K | Sell |
22,314
-6,937
| -24% | -$34.7K | ﹤0.01% | 3306 |
|
|
2019
Q2 | $139K | Sell |
29,251
-33,642
| -53% | -$159K | ﹤0.01% | 3157 |
|
|
2019
Q1 | $344K | Sell |
62,893
-29,734
| -32% | -$137K | ﹤0.01% | 2516 |
|
|
2018
Q4 | $281K | Buy |
92,627
+20,659
| +29% | +$71.6K | ﹤0.01% | 2496 |
|
|
2018
Q3 | $302K | Buy |
+71,968
| New | +$303K | ﹤0.01% | 2771 |
|
|
2015
Q3 | – | Sell |
-5,896
| Closed | -$574K | – | 3065 |
|
|
2015
Q2 | $574K | Sell |
5,896
-42,422
| -88% | -$4.04M | ﹤0.01% | 2028 |
|
|
2015
Q1 | $4.52M | Sell |
48,318
-2,447
| -5% | -$208K | 0.02% | 768 |
|
|
2014
Q4 | $4.51M | Buy |
50,765
+32,475
| +178% | +$2.37M | 0.03% | 674 |
|
|
2014
Q3 | $1.26M | Buy |
18,290
+9,479
| +108% | +$507K | 0.01% | 1001 |
|
|
2014
Q2 | $505K | Buy |
+8,811
| New | +$447K | ﹤0.01% | 1603 |
|
|
2014
Q1 | – | Sell |
-2,405
| Closed | -$101K | – | 2441 |
|
|
2013
Q4 | $101K | Buy |
+2,405
| New | +$69.7K | ﹤0.01% | 2082 |
|
Other funds holding MACK
RA
JC
Two Sigma Investments's MACK Position: Q2 2024 in Review
Two Sigma Investments sold out of Merrimack Pharmaceuticals, Inc. (MACK) in Q2 2024, closing a stake of 20,401 shares — an estimated $301K sold.
Two Sigma Investments first reported a position in MACK in Q4 2013 and held it in 23 quarters. The position peaked at $4.52M in Q1 2015. 12 funds tracked by Wall St. Rank hold MACK as of Q2 2024.
- Two Sigma Investments reported no remaining Merrimack Pharmaceuticals, Inc. position as of Q2 2024 after selling out during the quarter.
- Two Sigma Investments sold 20,401 Merrimack Pharmaceuticals, Inc. shares in Q2 2024, an estimated $301K.
- Two Sigma Investments first reported a position in Merrimack Pharmaceuticals, Inc. in Q4 2013 and held it in 23 quarters.
- Two Sigma Investments's Merrimack Pharmaceuticals, Inc. position peaked at $4.52M in Q1 2015.
- 12 funds tracked by Wall St. Rank held Merrimack Pharmaceuticals, Inc. as of Q2 2024.
Based on Two Sigma Investments's 13F filing for Q2 2024, filed 14 Aug 2024.